Florida Center For Allergy & Asthma Research is categorized under Allergists in Miami, FL and active since 1998.
Florida Center For Allergy & Asthma Research was established in 1998, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Allergists business, which does work in the B2C market, and is classified as a Allergists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Sharon Pena at the company’s single location by writing to 8970 Sw 87th Court # 100, Miami, Florida FL 33176 or by phoning (305) 273-2988. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Florida Center For Allergy & Asthma Research |
Contact Person: | Sharon Pena |
Address: | 8970 Sw 87th Court # 100, Miami, Florida 33176 |
Phone Number: | (305) 273-2988 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Allergists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Florida Center For Allergy & Asthma Research was started in 1998 to provide professional Allergists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sharon Pena for inquiries that concern Florida Center For Allergy & Asthma Research by calling the company number (305) 273-2988, as your correspondence is most welcome. Additionally, the physical location of the single location of Florida Center For Allergy & Asthma Research can be found at the coordinates 25.686476,-80.335731 as well as the street address 8970 Sw 87th Court # 100 in Miami, Florida 33176.
For its online presence, you may visit Florida Center For Allergy & Asthma Research’s website at and engage with its social media outlets through on Twitter and on Facebook.